Lie Ming Ding
Chief Executive Officer chez BETTA PHARMACEUTICALS CO., LTD.
Fortune : 60 M $ au 31/03/2024
Profil
Fondateur de Betta Pharmaceuticals Co., Ltd, Lie Ming Ding est actuellement président, co-directeur général et directeur général de Betta Pharmaceuticals Co., Ltd et directeur général et directeur exécutif de Ningbo Kaiming Venture Technology Co., Ltd, président et directeur général de Zhejiang Betta Pharmaceuticals Co., Ltd. (une filiale de Ningbo Kaiming Venture Technology Co., Ltd.). Le Dr Ding est également membre du conseil d'administration de Betta Investment (Hong Kong) Ltd. Dans le passé, il était associé de recherche principal à l'Institut du cancer de l'Université de l'Arkansas. Lie Ming Ding a obtenu un doctorat de l'université de l'Arkansas.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 9 924 563 ( 2,40% ) | 56 M $ | 31/03/2024 | |
| 30/09/2023 | 739 978 ( 56,97% ) | 4 M $ | 31/03/2024 |
Postes actifs de Lie Ming Ding
| Sociétés | Poste | Début |
|---|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Chief Executive Officer | 23/08/2013 |
Betta Investment (Hong Kong) Ltd.
 Betta Investment (Hong Kong) Ltd. Financial ConglomeratesFinance Betta Investment (Hong Kong) Ltd. engages in investment and trading. It invests in pharmaceutical research and development activities. The company was founded on October 14, 2014 and is headquartered in Hong Kong. | Director/Board Member | - |
Zhejiang Betta Pharmaceuticals Co., Ltd.
 Zhejiang Betta Pharmaceuticals Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China. | Chief Executive Officer | - |
Ningbo Kaiming Venture Technology Co., Ltd.
 Ningbo Kaiming Venture Technology Co., Ltd. Packaged SoftwareTechnology Services Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China. | Chief Executive Officer | - |
Wuhan Healthgen Biotechnology Corp.
 Wuhan Healthgen Biotechnology Corp. BiotechnologyHealth Technology Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China. | Director/Board Member | 20/06/2022 |
Anciens postes connus de Lie Ming Ding
| Sociétés | Poste | Fin |
|---|---|---|
| The University of Arkansas | Corporate Officer/Principal | - |
Formation de Lie Ming Ding
| The University of Arkansas | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. BiotechnologyHealth Technology Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China. | Health Technology |
Betta Investment (Hong Kong) Ltd.
Betta Investment (Hong Kong) Ltd. Financial ConglomeratesFinance Betta Investment (Hong Kong) Ltd. engages in investment and trading. It invests in pharmaceutical research and development activities. The company was founded on October 14, 2014 and is headquartered in Hong Kong. | Finance |
Zhejiang Betta Pharmaceuticals Co., Ltd.
Zhejiang Betta Pharmaceuticals Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China. | Commercial Services |
Ningbo Kaiming Venture Technology Co., Ltd.
Ningbo Kaiming Venture Technology Co., Ltd. Packaged SoftwareTechnology Services Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China. | Technology Services |
